MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions

M. Qurbonova, M. Isrofilov (Dushanbe, Tajikistan)

Meeting: 2025 International Congress

Keywords: Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To determine the differences in the age of onset of clinical manifestations and rate of progression of Parkinson’s disease in different regions of Tajikistan.

Background: Parkinson’s disease is one of the most common neurodegenerative diseases, the prevalence of which increases with age. In particular, data on the prevalence, clinical features, geographical distribution and the influence of climatic factors on the development and course of the disease in Tajikistan are not available, which justifies the need for this study.

Method: The study was conducted on the basis of the Republican Neurological Centre. The study involved 43 patients with diagnosed Parkinson’s disease. The average age of the patients was 55-75 years (± 2.5 years).

Results: Among the 43 patients, 27 (62.8%) were from urban areas and 16 (37.2%) from rural areas, of whom 7 (16.3%) lived in the highlands. An analysis of anamnestic data showed that the debut of the disease in patients from highland areas occurred on average 2.5-3 years later compared to other regions. However, age of onset and lateralisation of symptoms were not significantly different between the groups.Clinical analysis revealed that patients from high altitude areas had more severe non-motor symptoms, in particular depression and anxiety disorders. At the same time, the severity of motor manifestations on the Henna-Yar scale was less significant compared to the other groups, despite the same duration of the disease. However, among motor manifestations, stiffness was predominant in this group of patients, while tremor and postural instability were less pronounced.

Conclusion: The obtained data indicate a possible influence of environmental factors, such as the altitude of residence, on the clinical manifestations and course of Parkinson’s disease, which requires further study.

To cite this abstract in AMA style:

M. Qurbonova, M. Isrofilov. Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-manifestations-and-rate-of-progression-of-parkinsons-disease-in-different-regions/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-manifestations-and-rate-of-progression-of-parkinsons-disease-in-different-regions/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley